Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Bionano Genomics, Inc. (NASDAQ: BNGO)
BNGO Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
28.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
130.80%
BNGO Stock Analysis
BNGO
PE Ratio:
BNGO
PEG Ratio:
Not Available
BNGO
Forward EPS Growth (12 month):
0.00%
BNGO
PS Ratio:
0.1
BNGO
PSG Ratio:
BNGO
Forward Revenue Growth (12 month):
34.70%
BNGO Articles
No data was found